Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the mfn-opts domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6121
Despite Promising Safety Review, FDA Approves Another Generic Abortion Pill, by Nancy Flanders – Brown Pelican Society of Lousiana

Despite Promising Safety Review, FDA Approves Another Generic Abortion Pill, by Nancy Flanders

Daily Scripture Readings and Meditations: Your Names Are Written in Heaven

October 4, 2025

Recovering the real St. Francis of Assisi, David G. Bonagura, Jr.

October 4, 2025

Grok AI image.Building representing FDA and box of mifepristone

By Nancy Flanders, Live Action News, Oct 2, 2025

Live Action News is pro-life news and commentary from a pro-life perspective.

The FDA has just approved a new generic version of the Mifeprex (mifepristone 200mg) abortion pill, as evidenced by a letter sent to Evita Solutions, LLC, on September 30.

According to Dun & Bradstreet, the principal for Evita Solutions — a pharmaceutical manufacturer — is Robert Patane, and the business is located in Glen Allen, Virginia. According to Susan B. Anthony Pro-Life America, Evita Solutions describes its mission as one to “normalize abortion” and make it “accessible to all.”

Key Takeaways:

On Tuesday, the FDA quietly approved a new generic version of the abortion drug mifepristone.
The company behind the generic mifepristone is Evita Solutions LLC, which said its mission is to “normalize abortion” and make it “accessible to all.”
The decision comes just days after HHS Secretary Robert F. Kennedy Jr said that the FDA will be reviewing the safety of mifepristone.
Kennedy had previously accused the Biden administration of having “twisted the data” on the safety of the abortion pill. …..

Continue reading >>>>>>>>>>>